![David Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wilson
Founder at
WG Partners LLP
Net worth: 511 $ as of 30/06/2026
Profile
David Ian Wilson is the founder of WG Partners LLP, established in 2011, where the title held is Chairman.
Current jobs include Independent Non-Executive Director at Bionomics Ltd. since 2016, Director at CS Pharmaceuticals Ltd. since 2021, Non Executive Director at Chuangsheng Qiao Kang Pharmaceutical Co., Ltd., Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, Senior Board Advisor at Sapia Partners LLP, and Member-Governors Board at Harris Academy Bromley since 2015.
Former jobs include Chief Executive Officer at Piper Sandler Ltd., Deputy Chief Executive Officer at Matrix Corporate Capital LLP in 2011, Independent Non-Executive Director at Optos Plc from 2012 to 2013, Non-Executive Director at Oncoinvent ASA from 2013 to 2016, Head-Small Companies Corporate Finance at Deutsche Bank AG from 1998 to 1999, Joint Head-UK Investment Banking Group at ING Barings Group LLC from 1999 to 2001, and Head-Small Companies Corporate Broking at UBS AG (London Branch).
Education includes undergraduate degree from the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0% | 20/01/2026 | 117 ( 0% ) | 511 $ | 30/06/2026 |
David Wilson active positions
| Companies | Position | Start |
|---|---|---|
WG Partners LLP
 WG Partners LLP Investment Banks/BrokersFinance Provides brokerage services | Founder | 01/10/2011 |
Harris Academy Bromley | Director/Board Member | - |
Sapia Partners LLP
 Sapia Partners LLP Investment ManagersFinance Sapia Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Director/Board Member | 16/06/2016 |
CS Pharmaceuticals Ltd. | Director/Board Member | 01/07/2021 |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
 Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Director/Board Member | - |
Former positions of David Wilson
| Companies | Position | End |
|---|---|---|
| ONCOINVENT ASA | Director/Board Member | 01/01/2016 |
Matrix Corporate Capital LLP
 Matrix Corporate Capital LLP Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/10/2011 |
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Chief Executive Officer | 01/01/2011 |
| ░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of David Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Deutsche Bank AG /UK/
 Deutsche Bank AG /UK/ Investment Banks/BrokersFinance Deutsche Bank UK is an active manager which constructs tailored investment strategies in line with their clients' risk/reward profile for a variety of strategies including aggressive growth, growth, income or security. They construct portfolios comprised of asset classes such as bonds, equities, alternative investments and foreign exchange. The firm bases their investment decisions on the group's worldwide network of experts, in addition to their regional and local expertise. | Finance |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
ING Barings Group LLC
 ING Barings Group LLC Investment Banks/BrokersFinance Provides investment banking and financial services | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optos Plc
 Optos Plc Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets retinal imaging devices | Health Technology |
UBS AG (London Branch)
 UBS AG (London Branch) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Matrix Corporate Capital LLP
Matrix Corporate Capital LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Sapia Partners LLP
Sapia Partners LLP Investment ManagersFinance Sapia Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
WG Partners LLP
WG Partners LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harris Academy Bromley | |
CS Pharmaceuticals Ltd. | |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops ocular therapeutics and treatments for rare diseases | Commercial Services |
- Stock Market
- Insiders
- David Wilson
